Skip to content
★ Sign in to follow
GN

Garrett Nichols

Chimerix Inc
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (3 ops.)
€76k

Latest filing published 11 Feb 2020 for CHIMERIX INC, €3,947.

Filing timeline

BuySale
Garrett Nichols

Insider track record

Disclosed buys
0
Disclosed sells
3
Signal history

Garrett Nichols: trading record in brief

Garrett Nichols appears in our data through filings on Chimerix Inc shares, published by SEC (Form 4). The record holds 15 filings, for trades running from 9 May 2016 to 10 February 2020.

No open-market purchase appears, only 3 sales worth €76k. Besides market trades, the filings include 12 share grants. Since January 2020: no purchases and 3 sales on the market.

The newest entry dates from 11 February 2020: an open-market sale of €3,947, in Chimerix Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Garrett Nichols

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ▼
    Chief Medical OfficerExecutivesChimerix Inc
    4,335 USD23SEC
    2,550 shares@ US$1.703.9% of flowCommon StockSEC:0001209191-20-008297:0
  • ▼
    Chief Medical OfficerExecutivesChimerix Inc
    14,792 USD24SEC
    8,805 shares@ US$1.6813.5% of flowCommon StockSEC:0001209191-20-008297:1
  • ▼
    Chief Medical OfficerExecutivesChimerix Inc
    65,962 USD16SEC
    30,680 shares@ US$2.1548.8% of flowCommon StockSEC:0001209191-20-002630:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    26,611 USD13SEC
    7,625 shares@ US$3.4916.7% of flowCommon StockSEC:0001209191-19-043295:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    16,292 USD12SEC
    4,695 shares@ US$3.4710.2% of flowCommon StockSEC:0001209191-19-031951:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    0SEC
    100,000 shares0Common StockSEC:0001209191-19-008277:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    6,809 USD11SEC
    3,095 shares@ US$2.203.9% of flowCommon StockSEC:0001209191-19-005995:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    0SEC
    125,000 shares0Common StockSEC:0001209191-19-005359:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    26,469 USD12SEC
    5,680 shares@ US$4.6610.0% of flowCommon StockSEC:0001209191-18-030138:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    10,881 USD11SEC
    2,330 shares@ US$4.673.9% of flowCommon StockSEC:0001209191-18-007698:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    59,492 USD13SEC
    12,712 shares@ US$4.6824.7% of flowCommon StockSEC:0001209191-17-032836:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    2,407 USD11SEC
    587 shares@ US$4.101.0% of flowCommon StockSEC:0001209191-17-023888:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    0SEC
    30,375 shares0Common StockSEC:0001209191-17-005779:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    14,442 USD12SEC
    3,566 shares@ US$4.055.8% of flowCommon StockSEC:0001209191-16-142036:0
  • ◆
    Chief Medical OfficerExecutivesChimerix Inc
    0SEC
    75,000 shares0Common StockSEC:0001209191-16-119199:0

15 of 15 declarations